![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Maier, Sebastian H. 
ORCID: https://orcid.org/0000-0003-0120-8842; Schönecker, Stephan ORCID: https://orcid.org/0000-0003-0359-8960; Anagnostatou, Vasiliki ORCID: https://orcid.org/0009-0009-8438-2758; Garny, Sylvia; Nitschmann, Alexander ORCID: https://orcid.org/0009-0000-8620-2305; Fleischmann, Daniel F.; Büttner, Marcel; Kaul, David; Imhoff, Detlef ORCID: https://orcid.org/0000-0003-3627-7370; Fokas, Emmanouil; Seidel, Clemens ORCID: https://orcid.org/0000-0001-8178-5089; Hau, Peter; Kölbl, Oliver; Popp, Ilinca; Grosu, Anca-Ligia; Haussmann, Jan; Budach, Wilfried; Celik, Eren; Kahl, Klaus-Henning ORCID: https://orcid.org/0000-0002-0545-1367; Hoffmann, Elgin ORCID: https://orcid.org/0000-0002-9214-919X; Tabatabai, Ghazaleh; Paulsen, Frank; Holzgreve, Adrien ORCID: https://orcid.org/0000-0002-9566-8438; Albert, Nathalie L.; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Corradini, Stefanie; Belka, Claus; Niyazi, Maximilian und Bodensohn, Raphael ORCID: https://orcid.org/0000-0002-1114-2771
(2024):
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
In: Clinical and Translational Radiation Oncology, Bd. 47, 100790
[PDF, 10MB]
ORCID: https://orcid.org/0000-0003-0120-8842; Schönecker, Stephan ORCID: https://orcid.org/0000-0003-0359-8960; Anagnostatou, Vasiliki ORCID: https://orcid.org/0009-0009-8438-2758; Garny, Sylvia; Nitschmann, Alexander ORCID: https://orcid.org/0009-0000-8620-2305; Fleischmann, Daniel F.; Büttner, Marcel; Kaul, David; Imhoff, Detlef ORCID: https://orcid.org/0000-0003-3627-7370; Fokas, Emmanouil; Seidel, Clemens ORCID: https://orcid.org/0000-0001-8178-5089; Hau, Peter; Kölbl, Oliver; Popp, Ilinca; Grosu, Anca-Ligia; Haussmann, Jan; Budach, Wilfried; Celik, Eren; Kahl, Klaus-Henning ORCID: https://orcid.org/0000-0002-0545-1367; Hoffmann, Elgin ORCID: https://orcid.org/0000-0002-9214-919X; Tabatabai, Ghazaleh; Paulsen, Frank; Holzgreve, Adrien ORCID: https://orcid.org/0000-0002-9566-8438; Albert, Nathalie L.; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Corradini, Stefanie; Belka, Claus; Niyazi, Maximilian und Bodensohn, Raphael ORCID: https://orcid.org/0000-0002-1114-2771
(2024):
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
In: Clinical and Translational Radiation Oncology, Bd. 47, 100790
[PDF, 10MB]
Weidner, Lorraine; Lorenz, Julia; Quach, Stefanie; Braun, Frank K.; Rothhammer-Hampl, Tanja; Ammer, Laura-Marie; Vollmann-Zwerenz, Arabel; Bartos, Laura M.; Dekorsy, Franziska J.; Holzgreve, Adrien; Kirchleitner, Sabrina V.; Thon, Niklas; Greve, Tobias; Ruf, Viktoria; Herms, Jochen; Bader, Stefanie; Milenkovic, Vladimir M.; von Baumgarten, Louisa; Menevse, Ayse N.; Hussein, Abir; Sax, Julian; Wetzel, Christian H.; Rupprecht, Rainer; Proescholdt, Martin; Schmidt, Nils O.; Beckhove, Philipp; Hau, Peter; Tonn, Joerg-Christian; Bartenstein, Peter; Brendel, Matthias; Albert, Nathalie L. und Riemenschneider, Markus J.
(2023):
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
In: Acta Neuropathologica Communications, Bd. 11, Nr. 1, 147
[PDF, 6MB]
Zeyen, Thomas; Potthoff, Anna-Laura; Nemeth, Robert; Heiland, Dieter H.; Burger, Michael C.; Steinbach, Joachim P.; Hau, Peter; Tabatabai, Ghazaleh; Glas, Martin; Schlegel, Uwe; Grauer, Oliver; Krex, Dietmar; Schnell, Oliver; Goldbrunner, Roland; Sabel, Michael; Thon, Niklas; Delev, Daniel; Clusmann, Hans; Seidel, Clemens; Gueresir, Erdem; Schmid, Matthias; Schuss, Patrick; Giordano, Frank A.; Radbruch, Alexander; Becker, Albert; Weller, Johannes; Schaub, Christina; Vatter, Hartmut; Schilling, Judith; Winkler, Frank; Herrlinger, Ulrich und Schneider, Matthias
(2022):
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
In: Trials, Bd. 23, Nr. 1, 57
Tzaridis, Theophilos; Schaefer, Niklas; Weller, Johannes; Steinbach, Joachim-Peter; Schlegel, Uwe; Seidel, Sabine; Sabel, Michael; Hau, Peter; Seidel, Clemens; Krex, Dietmar; Goldbrunner, Roland; Tonn, Jörg-Christian; Grauer, Oliver; Kebir, Sied; Schneider, Matthias; Schaub, Christina; Vatter, Hartmut; Coch, Christoph; Glas, Martin; Fimmers, Rolf; Pietsch, Torsten; Reifenberger, Guido; Herrlinger, Ulrich und Felsberg, Jörg
(2020):
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
In: International Journal of Cancer, Bd. 148, Nr. 7: S. 1695-1707
Ammer, Laura-Marie; Vollmann-Zwerenz, Arabel; Ruf, Viktoria; Wetzel, Christian H.; Riemenschneider, Markus J.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Beckhove, Philipp und Hau, Peter
(2020):
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma.
In: Cancers, Bd. 12, Nr. 10, 2973
ORCID: https://orcid.org/0000-0003-0953-7624; Beckhove, Philipp und Hau, Peter
(2020):
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma.
In: Cancers, Bd. 12, Nr. 10, 2973
Kebir, Sied; Schaub, Christina; Junold, Nina; Hattingen, Elke; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Galldiks, Norbert; Weller, Johannes; Mack, Frederic; Tzaridis, Theophilos; Baehr, Oliver; Seidel, Clemens; Schlegel, Uwe; Schmidt-Graf, Friederike; Rohde, Veit; Borchers, Christian; Tabatabai, Ghazaleh; Haenel, Mathias; Sabel, Michael; Gerlach, Rüdiger; Krex, Dietmar; Belka, Claus; Vatter, Hartmut; Proescholdt, Martin; Glas, Martin und Herrlinger, Ulrich
(2019):
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
In: Journal of Neuro-Oncology, Bd. 144, Nr. 3: S. 501-509
Herrlinger, Ulrich; Tzaridis, Theophilos; Mack, Frederic; Steinbach, Joachim Peter; Schlegel, Uwe; Sabel, Michael; Hau, Peter; Kortmann, Rolf-Dieter; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Schnell, Oliver; Baehr, Oliver; Uhl, Martin; Seidel, Clemens; Tabatabai, Ghazaleh; Kowalski, Thomas; Ringel, Florian; Schmidt-Graf, Friederike; Suchorska, Bogdana; Brehmer, Stefanie; Weyerbrock, Astrid; Renovanz, Miriam; Bullinger, Lars; Galldiks, Norbert; Vajkoczy, Peter; Misch, Martin; Vatter, Hartmut; Stuplich, Moritz; Schäfer, Niklas; Kebir, Sied; Weller, Johannes; Schaub, Christina; Stummer, Walter; Tonn, Jörg-Christian; Simon, Matthias; Keil, Vera C.; Nelles, Michael; Urbach, Horst; Coenen, Martin; Wick, Wolfgang; Weller, Michael; Fimmers, Rolf; Schmid, Matthias; Hattingen, Elke; Pietsch, Torsten; Coch, Christoph und Glas, Martin
(2019):
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
In: Lancet, Bd. 393, Nr. 10172: S. 678-688
Schäfer, Niklas; Pröscholdt, Martin; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Grauer, Oliver; Goldbrunner, Roland; Friedrich, Franziska; Rohde, veit; Ringel, Florian; Schlegel, Uwe; Sabel, Michael; Ronellenfitsch, Michael W.; Uhl, Martin; Grau, Stefan; Hänel, Mathias; Schnell, Oliver; Krex, Dietmar; Vajkoczy, Peter; Tabatabai, Ghazaleh; Mack, Frederic; Schaub, Christina; Tzaridis, Theophilos; Niessen, Michael; Kebir, Sied; Leutgeb, Barbara; Urbach, Horst; Belka, Claus; Stummer, Walter; Glas, Martin und Herrlinger, Ulrich
(2018):
Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
In: Neuro-Oncology, Bd. 20, Nr. 7: S. 975-985
Schaub, Christina; Kebir, Sied; Junold, Nina; Hattingen, Elke; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Niessen, Michael; Mack, Frederic; Stuplich, Moritz; Tzaridis, Theophilos; Bähr, Oliver; Kortmann, Rolf-Dieter; Schlegel, Uwe; Schmidt-Graf, Friederike; Rohde, Veit; Braun, Christian; Haenel, Mathias; Sabel, Michael; Gerlach, Rüdiger; Krex, Dietmar; Belka, Claus; Vatter, Hartmut; Pröscholdt, Martin; Herrlinger, Ulrich und Glas, Martin
(2018):
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 8: S. 1581-1589
Happold, Caroline; Felsberg, Jörg; Clarke, Jennifer; Soffietti, Riccardo; Marosi, Christine; Krex, Dietmar; Ducray, Francois; Hau, Peter; Reijneveld, Jaap; Weyerbrock, Astrid; Wick, Antje; Reardon, David; Glas, Martin; Razis, Evangelia; Herrlinger, Ulrich; Tonn, Jörg-Christian; Carpentier, Antoine F.; Lefranc, Florence; Rhun, Emilie le; Verschuere, Tina; Golfinopoulos, Vassilis; Klein, Martin; Reifenberger, Guido und Weller, Michael
(2017):
Molecular Genetic, Host-Derived and Clinical Determinants of Long-Term Survival in Glioblastoma: First Results from the Brain Tumor Funders' Collaborative Consortium.
In: Neuro-Oncology, Bd. 19: S. 5-6
Herrlinger, Ulrich; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Friedrich, Franziska; Rohde, Veit; Ringel, Florian; Schlegel, Uwe; Sabel, Michael; Ronellenfitsch, Michael W.; Uhl, Martin; Maciaczyk, Jaroslaw; Grau, Stefan; Schnell, Oliver; Hänel, Mathias; Krex, Dietmar; Vajkoczy, Peter; Gerlach, Rüdiger; Kortmann, Rolf-Dieter; Mehdorn, Maximilian; Tüttenberg, Jochen; Mayer-Steinacker, Regine; Fietkau, Rainer; Brehmer, Stefanie; Mack, Frederic; Stuplich, Moritz; Kebir, Sied; Kohnen, Ralf; Dunkl, Elmar; Leutgeb, Barbara; Proescholdt, Martin; Pietsch, Torsten; Urbach, Horst; Belka, Claus; Stummer, Walter und Glas, Martin
(2016):
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
In: Journal of Clinical Oncology, Bd. 34, Nr. 14:
1611-U134
Illerhaus, Gerald; Kasenda, Benjamin; Ihorst, Gabriele; Egerer, Gerlinde; Lamprecht, Monika; Keller, Ulrich; Wolf, Hans-Heinrich; Hirt, Carsten; Stilgenbauer, Stephan; Binder, Mascha; Hau, Peter; Edinger, Matthias; Frickhofen, Norbert; Bentz, Martin; Möhle, Robert; Röth, Alexander; Pfreundschuh, Michael; Baumgarten, Louisa von; Deckert, Martina; Hader, Claudia; Fricker, Heidi; Valk, Elke; Schorb, Elisabeth; Fritsch, Kristina und Finke, Jürgen
(2016):
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
In: Lancet Haematology, Bd. 3, Nr. 8, E388-E397
Suchorska, Bogdana; Weller, Michael; Tabatabai, Ghazaleh; Senft, Christian; Hau, Peter; Sabel, Michael C.; Herrlinger, Ulrich; Ketter, Ralf; Schlegel, Uwe; Marosi, Christine; Reifenberger, Guido; Wick, Wolfgang; Tonn, Jörg C. und Wirsching, Hans-Georg
(2016):
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
In: Neuro-Oncology, Bd. 18, Nr. 4: S. 549-556